A prospective pilot study of thymoglobulin, cyclosporine (CSA) and MMF as GVHD prophylaxis in unrelated donor (URD) HCT using fludarabine and melphalan (flu/mel) for high-risk patients with hematological malignancies

R Rodriguez,A Nademanee,Y Fang,A Dagis,F Sahebi,P Parker,D Snyder,E Smith,R Nakamura,V Pullarkat,D Senitzer,J Zain,A Stein,K Patane,S Forman

doi:10.1016/j.bbmt.2005.11.192

A prospective pilot study of thymoglobulin, cyclosporine (CSA) and MMF as GVHD prophylaxis in unrelated donor (URD) HCT using fludarabine and melphalan (flu/mel) for high-risk patients with hematological malignancies

R Rodriguez, A Nademanee + Show 13 more

Open Access

https://doi.org/10.1016/j.bbmt.2005.11.192

Copy DOI

Journal: Biology of Blood and Marrow Transplantation	Publication Date: Feb 1, 2006
License type: cc-by-nc-nd

Affiliation: City of Hope, Los Angeles Medical Center

#GVHD Prophylaxis #Unrelated Donor HCT + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

A prospective pilot study of thymoglobulin, cyclosporine (CSA) and MMF as GVHD prophylaxis in unrelated donor (URD) HCT using fludarabine and melphalan (flu/mel) for high-risk patients with hematological malignancies

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Biology of Blood and Marrow Transplantation

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.